CILcare, a preclinical provider in otology, will hold a free webinar on July 9 at 8 pm (CEST) called “How to Assess Drug Candidates on Tinnitus Preclinical Models For a Successful Transition to Clinical Trials.”
Tinnitus is one of the most common hearing disorders, for which there is no drug on the market yet. CILcare’s speaker, Dr Sylvie Pucheu, CSO of Neuroservices-Alliance’s member CILcare, will present two preclinical models developed by CILcare for inducing and detecting tinnitus: Salicylate-induced and Noise-induced models. Pucheu will also provide insights on the readouts provided by these two models for a successful transition to clinical trials.
The webinar will include a 20-minute presentation followed by a 10-minute live Q & A. You can join the session by using a Mac, PC, or mobile device. For those who can’t join the presentation live, a recording will be provided if you’ve registered for the webinar.
This webinar is co-organized with Neuroservices-Alliance, CILcare’s CRO partner specialized in CNS disorders.
To register, please click here.
Source: CILcare
Image: CILcare
